Use of drugs in the treatment of parkinsonism.
D000547:Amantadine / Q000494:pharmacology / Q000627:therapeutic use*; D003863:Depression / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced
D004295:Dihydroxyphenylalanine; D000547:Amantadine